ICONIC THERAPEUTICS INC

Profile

Company Names

ICONIC THERAPEUTICS INC

Addresses

442 LITTLEFIELD AVENUE, SOUTH SAN FRANCISCO, CA 94080

7000 SHORELINE COURT, SUITE 270, SOUTH SAN FRANCISCO, CA 94080

395 OYSTER POINT BOULEVARD, SUITE 515, SOUTH SAN FRANCISCO, CA 94080

127 PEACHTREE ST STE 1551, ATLANTA, 2Q 30303

Phone Numbers

650-437-1000
404-522-8577

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$78,960,247.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2019-04-15 
$13,031,025.00 
$16,300,000.00 
$3,268,975.00 
Equity 
3
2018-06-05 
$4,109,317.00 
$10,900,000.00 
$6,790,683.00 
Debt 
2
2015-12-24 
$48,561,000.00 
$48,561,000.00 
$0.00 
Equity 
1
2014-04-14 
$13,258,905.00 
$24,266,880.00 
$11,007,975.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
BRUCE 
 
COHEN 
DIRECTOR
PLUMCHOICE INC   |  RIVULET COMMUNICATIONS INC   |  VITAPATH GENETICS, INC.   |  BIG FISH BROADWAY LTD LIABILITY CO   |  RAPID MICRO BIOSYSTEMS, INC.   |  CORTLAND GROWTH + INCOME REIT, LLC   |  ICONIC THERAPEUTICS INC   |  NORCOH HOLDINGS, LLC-SERIES E
KIRK 
 
DORNBUSH 
DIRECTOR, EXECUTIVE OFFICER
ICONIC THERAPEUTICS INC
TODD 
 
FOLEY 
DIRECTOR
RHYTHM PHARMACEUTICALS, INC.   |  ZALICUS INC.   |  CELLADON CORP   |  SELEXYS PHARMACEUTICALS CORP   |  PROTEON THERAPEUTICS INC   |  ICONIC THERAPEUTICS INC   |  VALERITAS INC   |  TETHEREX PHARMACEUTICALS CORP   |  CLINICAL INK, INC.   |  SEMMA THERAPEUTICS, INC.   |  RHYTHM METABOLIC, INC.   |  RHYTHM PHARMACEUTICALS, INC.   |  ENTRADA THERAPEUTICS, INC.   |  MOAT BIOTECHNOLOGY CORP   |  CROSSBOW THERAPEUTICS, INC.   |  FIREFLY BIO, INC.   |  AKTIS ONCOLOGY, INC.
WILLIAM 
 
GREENE 
EXECUTIVE OFFICER, DIRECTOR
NEOVISTA INC   |  ENDOGASTRIC SOLUTIONS INC   |  MPM BIOVENTURES V, L.P.   |  THERACLONE SCIENCES, INC.   |  ICONIC THERAPEUTICS INC   |  FOUNTAIN THERAPEUTICS, INC.   |  BANYAN INFRASTRUCTURE CORP   |  AEOVIAN PHARMACEUTICALS, INC.
JULIA 
 
GREGORY 
DIRECTOR
CLINIPACE INC   |  ICONIC THERAPEUTICS INC   |  NURIX THERAPEUTICS, INC.   |  IMV INC.
PETER 
 
HIRTH 
DIRECTOR
KOLLTAN PHARMACEUTICALS INC   |  ALIOS BIOPHARMA INC   |  AFFERENT PHARMACEUTICALS, INC.   |  ICONIC THERAPEUTICS INC   |  SUTROVAX, INC.   |  ALIGOS THERAPEUTICS, INC.   |  ESCIENT PHARMACEUTICALS INC   |  TREX HOLDINGS INC.
JOHAN 
 
KORDEL 
DIRECTOR
CELLADON CORP   |  RIVER VISION DEVELOPMENT CORP.   |  ICONIC THERAPEUTICS INC   |  CURZION PHARMACEUTICALS, INC.   |  AMPLYX PHARMACEUTICALS, INC.
BRUCE 
 
ROBERTSON 
DIRECTOR
APOLLO ENDOSURGERY INC   |  CARDIOFOCUS, INC.   |  WILD STREAM EXPLORATION INC.   |  CEREPHEX CORP   |  ICONIC THERAPEUTICS INC   |  SOFT-TEX HOLDINGS INC.   |  RXSIGHT, INC.   |  INTACT VASCULAR, INC.   |  APOLLO ENDOSURGERY, INC.   |  ZERIGO HEALTH, INC.
JON 
 
SODERSTROM 
DIRECTOR
ICONIC THERAPEUTICS INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2019-04-26
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-04-15 
2018-06-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2018-06-05 
2016-11-02
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-12-24 
2016-01-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-12-24 
2014-04-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-04-14 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#